Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1995 1
1998 1
2002 1
2003 2
2004 3
2005 3
2006 2
2007 6
2008 3
2009 9
2010 11
2011 13
2012 13
2013 18
2014 24
2015 30
2016 28
2017 34
2018 32
2019 31
2020 40
2021 37
2022 55
2023 85
2024 77
2025 75
2026 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Results by year

Filters applied: . Clear all
Page 1
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial.
Duan J, Sun Y, Wang Q, Xing L, Wu L, Han L, Chen J, Liu B, Lu P, Shi H, Yu X, Zhang J, Zhang G, Hu Y, Cheng Y, Sun H, Yang H, Zhang Z, Ning F, He Z, Yao W, Dong Y, Zhang M, Song B, Zhou Y, Mao X, Liu Q, Wang J. Duan J, et al. Among authors: ning f. Cancer Cell. 2026 Apr 13;44(4):846-857.e3. doi: 10.1016/j.ccell.2026.02.006. Epub 2026 Mar 5. Cancer Cell. 2026. PMID: 41791381 Free article. Clinical Trial.
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yin Y, Zhang Q, Sun T, Hao C, Wang Z, Yang J, Wang Y, Shi Y, Sun J, Ouyang Q, Su H, Wu J, Gan L, Han M, Gao L, Wang X, Zhao B, Li H, Zhao J, Yang H, Ning F, Tian F, Zhang J, Sun H, Niu Z, Zong H, Zang A, Wang X, Qian X, Wu S, Nie J, He L, Cheng Y, Hao Y, Zhai Y, Li H, Wang J, Wei S, Li M, Liu Y, Guo H, Hu Q, Liu L, Han X, Luo R, Ni M, Tang X, Zhai Z, Ding M, Wang H, Shen P, Wang X, Liu L, Chen W, Liu G, Cai Z, Jiang Z. Yin Y, et al. Among authors: ning f. Signal Transduct Target Ther. 2025 Dec 18;10(1):414. doi: 10.1038/s41392-025-02475-6. Signal Transduct Target Ther. 2025. PMID: 41413016 Free PMC article. Clinical Trial.
Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease.
Folestad E, Mehlem A, Ning FC, Oosterveld T, Palombo I, Singh J, Olauson H, Witasp A, Thorell A, Stenvinkel P, Ebefors K, Nyström J, Eriksson U, Falkevall A. Folestad E, et al. Among authors: ning fc. Kidney Int. 2025 Mar;107(3):492-507. doi: 10.1016/j.kint.2024.11.026. Epub 2024 Dec 15. Kidney Int. 2025. PMID: 39689809 Free article.
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Li YS, Yu Q, Bu Q, Lin L, Ning F, Zhao Y, Wu G, Lin G, Zang A, Sun H, Huang J, Tu HY, Ma S, Zhou C, Liu A, Wang C, Yao Y, Han G, Zhao J, Zhou Q, Yan HH, Liu SM, Zheng MM, Lv J, Cheng F, Chen Z, Zhong WZ, Pan Y, Yang JJ, Wu YL. Li YS, et al. Among authors: ning f. J Thorac Oncol. 2025 Jul;20(7):928-940. doi: 10.1016/j.jtho.2025.02.004. Epub 2025 Feb 8. J Thorac Oncol. 2025. PMID: 39929333 Free article. Clinical Trial.
593 results